Independent register of U.S. FDA drug recalls · updated Oct 13, 2026
RxRecalls Get alerts

FDA Drug Recalls

14,806 recalls, newest first

Class II · Moderate risk

biotene PBF Toothpaste

Presence of Foreign Substance: Fragments of wood found when the product was extruded onto a toothbrush.

Terminated Particulate / foreign matter GlaxoSmithkline Consmer Healthcare NDC 0135-0559-01 D-1320-2015
Class II · Moderate risk

biotene Gentle Mint Gel

Presence of Foreign Substance: Fragments of wood found when the product was extruded onto a toothbrush.

Terminated Particulate / foreign matter GlaxoSmithkline Consmer Healthcare NDC 0135-0488-01 D-1317-2015
Class III · Low risk

Phentermine Hydrochloride Capsules

Failed Impurities/Degradation Specifications: out-of-specification results for individual unknown and total impurity at the 12th month room temperature stability test station

Terminated Impurity / degradation KVK-Tech, Inc. NDC 10702-0026-01 D-1371-2015
Class III · Low risk

Intermezzo

Failed dissolution specifications

Terminated Dissolution failure Purdue Pharma L.P. NDC 59011-265-30 D-1278-2015
Class II · Moderate risk

Clonidine Hydrochloride Tablets

cGMP Deviations; Clonidine hydrochloride drug substance used in the manufacturing of this product, was dispensed in unauthorized rooms by the drug substance manufacturer

Terminated cGMP deviation Mutual Pharmaceutical Company, Inc. NDC 53489-217-01 D-1282-2015
Class II · Moderate risk

Clonidine Hydrochloride Tablets

cGMP Deviations; Clonidine hydrochloride drug substance used in the manufacturing of this product, was dispensed in unauthorized rooms by the drug substance manufacturer

Terminated cGMP deviation Mutual Pharmaceutical Company, Inc. NDC 53489-216-01 D-1281-2015
Class II · Moderate risk

Clonidine Hydrochloride Tablets

cGMP Deviations; Clonidine hydrochloride drug substance used in the manufacturing of this product, was dispensed in unauthorized rooms by the drug substance manufacturer

Terminated cGMP deviation Mutual Pharmaceutical Company, Inc. NDC 53489-215-01 D-1280-2015
Class II · Moderate risk

0.9% Sodium Chloride Injection USP

Presence of Particulate Matter and Lack of Assurance of Sterility: The firm received a complaint for customer of presence of particulate matter, leaky containers, and missing port protectors.

Terminated Sterility / contamination Baxter Healthcare Corp. NDC 0338-0049-03 D-1326-2015

Recalls by year